Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-24-206165
Filing Date
2024-08-23
Accepted
2024-08-23 16:04:07
Documents
46
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d882103d10q.htm   iXBRL 10-Q 834821
2 EX-31.1 d882103dex311.htm EX-31.1 10553
3 EX-31.2 d882103dex312.htm EX-31.2 10574
4 EX-32.1 d882103dex321.htm EX-32.1 3854
5 EX-32.2 d882103dex322.htm EX-32.2 3875
  Complete submission text file 0001193125-24-206165.txt   4999368

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA acab-20240630.xsd EX-101.SCH 55048
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acab-20240630_cal.xml EX-101.CAL 21589
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acab-20240630_def.xml EX-101.DEF 287987
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acab-20240630_lab.xml EX-101.LAB 331433
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acab-20240630_pre.xml EX-101.PRE 315834
49 EXTRACTED XBRL INSTANCE DOCUMENT d882103d10q_htm.xml XML 642670
Mailing Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013
Business Address 6 ST JOHNS LANE, FLOOR 5 NEW YORK NY 10013 248-890-7200
Atlantic Coastal Acquisition Corp. II (Filer) CIK: 0001893219 (see all company filings)

EIN.: 871013956 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41224 | Film No.: 241236254
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)